Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7

被引:51
作者
Bergstrom, Alexander [1 ]
Katko, Andrew [1 ]
Adkins, Zach [1 ]
Hill, Jessica [1 ]
Cheng, Zishuo [1 ]
Burnett, Mia [1 ]
Yang, Hao [1 ]
Aitha, Mahesh [1 ]
Mehaffey, M. Rachel [2 ]
Brodbelt, Jennifer S. [2 ]
Tehrani, Kamaleddin H. M. E. [3 ]
Martin, Nathaniel I. [3 ]
Bonomo, Robert A. [4 ]
Page, Richard C. [1 ]
Tierney, David L. [1 ]
Fast, Walter [5 ]
Wright, Gerard D. [6 ,7 ]
Crowder, Michael W. [1 ]
机构
[1] Miami Univ, Dept Chem & Biochem, 650 East High St, Oxford, OH 45056 USA
[2] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Chem Biol & Drug Discovery, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[4] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, 10701 East Blvd, Cleveland, OH USA
[5] Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, 107 W Dean Keeton, Austin, TX 78712 USA
[6] McMaster Univ, Michael G DeGroote Inst Infect Dis, 1280 Main St West, Hamilton, ON L8S 4L8, Canada
[7] McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St West, Hamilton, ON L8S 4L8, Canada
来源
ACS INFECTIOUS DISEASES | 2018年 / 4卷 / 02期
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
aspergillomarasmine A; metallo-beta-lactamase; NDM-1; VIM-2; IMP-7; antibiotic resistance; SPECTROSCOPIC CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISMS; MULTIDRUG-RESISTANT; STRUCTURAL BASIS; ACTIVE-SITE; INHIBITORS; NMR; COORDINATION; COBALT(II);
D O I
10.1021/acsinfecdis.7b00106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metallo-beta-lactamases (MBLs) are a growing threat to the continued efficacy of beta-lactam antibiotics. Recently, aspergillomarasmine A (AMA) was identified as an MBL inhibitor, but the mode of inhibition was not fully characterized. Equilibrium dialysis and metal analysis studies revealed that 2 equiv of AMA effectively removes 1 equiv of Zn(II) from MBLs NDM-1, VIM-2, and IMP-7 when the MBL is at micromolar concentrations. Conversely, H-1 NMR studies revealed that 2 equiv of AMA remove 2 equiv of Co(II) from Co(II)-substituted NDM-1, VIM-2, and IMP-7 when the MBL/AMA are at millimolar concentrations. Our findings reveal that AMA inhibits the MBLs by removal of the active site metal ions required for beta-lactam hydrolysis among the most clinically significant MBLs.
引用
收藏
页码:135 / 145
页数:11
相关论文
共 65 条
  • [1] Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gks1189, 10.1093/nar/gkx1095, 10.1093/nar/gkq1172]
  • [2] Biochemical, Mechanistic, and Spectroscopic Characterization of Metallo-β-lactamase VIM-2
    Aitha, Mahesh
    Marts, Amy R.
    Bergstrom, Alex
    Moller, Abraham Jon
    Moritz, Lindsay
    Tumer, Lucien
    Nix, Jay C.
    Bonomo, Robert A.
    Page, Richard C.
    Tierney, David L.
    Crowder, Michael W.
    [J]. BIOCHEMISTRY, 2014, 53 (46) : 7321 - 7331
  • [3] Bahr G., 2017, ANTIMICROB AGENTS CH
  • [4] H-1 NUCLEAR-MAGNETIC-RESONANCE INVESTIGATION OF COBALT(II) SUBSTITUTED CARBONIC-ANHYDRASE
    BANCI, L
    DUGAD, LB
    LAMAR, GN
    KEATING, KA
    LUCHINAT, C
    PIERATTELLI, R
    [J]. BIOPHYSICAL JOURNAL, 1992, 63 (02) : 530 - 543
  • [5] Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily
    Bebrone, Carine
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (12) : 1686 - 1701
  • [6] Bennett B, 2010, BIOL MAGN RESON, V29, P345, DOI 10.1007/978-1-4419-1139-1_10
  • [7] BERTINI I, 1989, METHOD ENZYMOL, V177, P246
  • [8] Bertini I, 1984, Adv Inorg Biochem, V6, P71
  • [9] Molecular mechanisms of antibiotic resistance
    Blair, Jessica M. A.
    Webber, Mark A.
    Baylay, Alison J.
    Ogbolu, David O.
    Piddock, Laura J. V.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2015, 13 (01) : 42 - 51
  • [10] Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers
    Brem, Juergen
    van Berkel, Sander S.
    Zollman, David
    Lee, Sook Y.
    Gileadi, Opher
    McHugh, Peter J.
    Walsh, Timothy R.
    McDonough, Michael A.
    Schofield, Christopher J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 142 - 150